Antibody-drug conjugates in breast cancer: Progress and future directions.
2/5 보강
OpenAlex 토픽 ·
HER2/EGFR in Cancer Research
Advanced Breast Cancer Therapies
Breast Cancer Treatment Studies
Antibody-drug conjugates (ADCs) have transformed the treatment landscape of breast cancer, enabling targeted delivery of potent cytotoxic payloads to antigen-expressing tumor cells.
APA
Alexandra Bili Newman, Senthil Damodaran, Funda Meric-Bernstam (2026). Antibody-drug conjugates in breast cancer: Progress and future directions.. Cell reports. Medicine, 102742. https://doi.org/10.1016/j.xcrm.2026.102742
MLA
Alexandra Bili Newman, et al.. "Antibody-drug conjugates in breast cancer: Progress and future directions.." Cell reports. Medicine, 2026, pp. 102742.
PMID
41950928 ↗
Abstract 한글 요약
Antibody-drug conjugates (ADCs) have transformed the treatment landscape of breast cancer, enabling targeted delivery of potent cytotoxic payloads to antigen-expressing tumor cells. These agents have demonstrated efficacy across breast cancer subtypes, including chemotherapy-refractory disease and brain metastases, with manageable side-effect profiles. However, despite significant advances, identifying predictive biomarkers for response and understanding resistance mechanisms remain critical challenges that must be addressed to guide rational sequencing strategies and optimize combination approaches. The ADC platform offers remarkable versatility through diverse antigen targeting, variable linker chemistries enabling controlled payload release, multiple cytotoxic payload classes, and adjustable drug-to-antibody ratios. Next-generation platforms including bispecific targeting constructs, immune-stimulating antibody conjugates, and novel payloads such as PROTACs and RNA polymerase II inhibitors are being developed to further expand therapeutic applications. Realizing the full potential of these agents will require integrated biomarker development, a deeper understanding of resistance mechanisms, and optimized sequencing and combination strategies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.
- Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.